TURBOVAS-F TAB

About

This medication combines a statin, atorvastatin, and a fibrate, fenofibrate, to provide comprehensive management for dyslipidemia. Atorvastatin, an HMG-CoA reductase inhibitor, significantly reduces the liver's production of cholesterol, leading to lower levels of LDL-C, total cholesterol, and triglycerides, while also modestly increasing HDL-C. Fenofibrate, by activating peroxisome proliferator-activated receptor alpha (PPARα), enhances the breakdown and removal of triglyceride-rich particles from the bloodstream and further boosts HDL-C. This synergistic combination is particularly indicated for patients with mixed dyslipidemia, characterized by elevated triglycerides and LDL-C, and often low HDL-C, where monotherapy with either agent alone has proven insufficient. By effectively improving the overall lipid profile, this medication plays a crucial role in reducing the risk of major cardiovascular events, offering a robust therapeutic option for complex lipid disorders.

Uses

• Treatment of mixed dyslipidemia.
• Reduction of elevated total cholesterol and LDL-C.
• Lowering high triglyceride levels.
• Increasing low HDL-C levels.

Directions For Use

Take this medication orally, usually once daily with or without food, as directed by your physician. Do not crush or chew the tablet.

Benefits

• Comprehensive lipid profile improvement.
• Significant reduction in LDL-C and triglycerides.
• Effective in managing mixed dyslipidemia.
• Reduces the risk of cardiovascular events.
• Increases beneficial HDL-C levels.
• Convenient combination therapy.

Side Effects

• Muscle pain (myalgia)
• Headache
• Nausea
• Diarrhea
• Abdominal pain
• Elevated liver enzymes
• Fatigue
• Insomnia
• Joint pain (arthralgia)
• Pancreatitis (rare)
• Gallstones (rare)
• Rhabdomyolysis (very rare, severe muscle breakdown)

Safety Measures

• Alcohol - Excessive alcohol consumption should be avoided as it can increase the risk of liver damage, a potential side effect of both atorvastatin and fenofibrate.
• Pregnancy - Contraindicated during pregnancy due to potential harm to the fetus. Effective contraception is required for women of childbearing potential.
• Breastfeeding - Not recommended during breastfeeding as the medication may pass into breast milk and could harm the infant.
• Liver - Contraindicated in patients with active liver disease or unexplained persistent elevations of serum transaminases. Use with caution in patients with a history of liver disease.
• Kidney - Use with caution and dose adjustment may be necessary in patients with moderate to severe renal impairment, especially with fenofibrate.
• Lung - Generally safe for use in patients with lung conditions, but any new or worsening respiratory symptoms should be reported to a physician.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.